HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Repeat laser coagulation of subretinal neovascularization in age-related macular degeneration].

AbstractINTRODUCTION:
Retinal laser coagulation (LC) of extrafoveal subretinal neovascularization (SRN) due to age-related macular degeneration (AMD) is the only sure therapy. Diagnostics, therapy and follow-up are presented in a case report.
CASE REPORT:
A 55-year-old woman had suffered from progressive reduction of visual acuity (with metamorphopsia) in both eyes (LE > RE) for 3 years. In the RE the visual acuity was 0.32 and in the LE 0.05. Funduscopy and fluorescein angiography revealed in both eyes the wet form of AMD. The extrafovealy located SRN of the RE was photocoagulated and had to be retreated three-times in 6 weeks due to persistence. For 8 months the findings in the RE have been stable. VA has been improved to 0.4 and no metamorphopsia has been found.
CONCLUSION:
Extrafoveal SRN should be treated by LC. Short-term follow-up (including FA) and in most cases several LCs are necessary to close the SRN and save the patients' reading vision.
AuthorsR Krott, G Rössler, K Heimann
JournalDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (Ophthalmologe) Vol. 96 Issue 10 Pg. 668-72 (Oct 1999) ISSN: 0941-293X [Print] Germany
Vernacular TitleMehrfache Laserkoagulation einer subretinalen Neovaskularisation bei altersabhängiger Makuladegeneration.
PMID10552161 (Publication Type: Case Reports, Comparative Study, English Abstract, Journal Article)
Topics
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Laser Coagulation
  • Macular Degeneration (diagnosis, surgery)
  • Middle Aged
  • Reoperation
  • Retinal Neovascularization (diagnosis, surgery)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: